|By Business Wire||
|August 18, 2014 12:40 PM EDT||
Research and Markets (http://www.researchandmarkets.com/research/53xwbk/global) has announced the addition of the "Global Regenerative Medicines Market (Technology, Application and Geography) - Size, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020" report to their offering.
According to a new market research report titled, "Global Regenerative Medicine Market (Technology, Applications, Geography) - Industry Analysis, Trends, Opportunities and Forecast, 2013-2020", the global regenerative medicine market will reach $ 67.6 billion by 2020 from $16.4 billion in 2013, registering a CAGR of 23.2% during forecast period (2014 - 2020). Small molecules and biologics segment holds prominent market share in the overall regenerative medicine technology market and is anticipated to grow at a CAGR of 18.9% during the forecast period.
Regenerative medicines have the ability to restore the lost functionality of tissues or organs, unlike conventional medicines, which are palliative. The immense potential of these medicines in repairing or regenerating diseased organs is the major reason for intensive focus on research and development in this field. The technologies implemented for these medicines utilize various cell types including stem cells. The advancements in nanotechnology and stem cells application would account for further progress of this novel field of medicine. The global regenerative medicine market is segmented based on technologies into small molecules and biologics, gene therapy and cell therapy.
Key Topics Covered:
CHAPTER 1. INTRODUCTION
CHAPTER 2. EXECUTIVE SUMMARY
CHAPTER 3. GLOBAL REGENERATIVE MEDICINES MARKET OVERVIEW
CHAPTER 4. GLOBAL REGENERATIVE MEDICINE MARKET BY TECHNOLOGIES
CHAPTER 5. GLOBAL REGENERATIVE MEDICINE MARKET BY APPLICATIONS
CHAPTER 6. GLOBAL REGENERATIVE MEDICINES MARKET BY GEOGRAPHY
CHAPTER 7. COMPANY PROFILES
- Advanced Cell Technology
- Athersys Inc.
- Cytori Therapeutics
- Kinetic Concepts
- Mesoblast Ltd.
- Shire pharmaceuticals
- Stem Cells
For more information visit http://www.researchandmarkets.com/research/53xwbk/global
Without a clear strategy for cost control and an architecture designed with cloud services in mind, costs and operational performance can quickly get out of control. To avoid multiple architectural redesigns requires extensive thought and planning. Boundary (now part of BMC) launched a new public-facing multi-tenant high resolution monitoring service on Amazon AWS two years ago, facing challenges and learning best practices in the early days of the new service. In his session at 19th Cloud Exp...
Dec. 3, 2016 03:00 PM EST Reads: 441
Dec. 3, 2016 02:45 PM EST Reads: 468
Dec. 3, 2016 02:45 PM EST Reads: 666
Dec. 3, 2016 02:45 PM EST Reads: 758
Dec. 3, 2016 02:45 PM EST Reads: 623
Dec. 3, 2016 02:15 PM EST Reads: 6,943
Dec. 3, 2016 02:00 PM EST Reads: 2,467
Dec. 3, 2016 02:00 PM EST Reads: 442
Dec. 3, 2016 01:30 PM EST Reads: 2,116
Dec. 3, 2016 01:15 PM EST Reads: 595
Dec. 3, 2016 01:00 PM EST Reads: 1,853
Dec. 3, 2016 01:00 PM EST Reads: 287
Dec. 3, 2016 12:45 PM EST Reads: 3,767
Dec. 3, 2016 12:45 PM EST Reads: 1,943
Dec. 3, 2016 12:45 PM EST Reads: 728